The global procurement landscape of leishmaniasis medicines.
Ensuring access to essential medicines for leishmaniasis control is challenging, as leishmaniasis is a very small and unattractive market for pharmaceutical industry. Furthermore, control programmes are severely underfunded. We conducted an analysis of global procurement of leishmaniasis medicines f...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-02-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009181&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849469891689578496 |
|---|---|
| author | Hye Lynn Choi Saurabh Jain José A Ruiz Postigo Bettina Borisch Daniel Argaw Dagne |
| author_facet | Hye Lynn Choi Saurabh Jain José A Ruiz Postigo Bettina Borisch Daniel Argaw Dagne |
| author_sort | Hye Lynn Choi |
| collection | DOAJ |
| description | Ensuring access to essential medicines for leishmaniasis control is challenging, as leishmaniasis is a very small and unattractive market for pharmaceutical industry. Furthermore, control programmes are severely underfunded. We conducted an analysis of global procurement of leishmaniasis medicines for the past 5 years in order to shed light on the current leishmaniasis market landscape and supply and demand dynamics. We estimated global demand of each leishmaniasis medicines, the amount of each medicine required to treat all reported cases, based on the number of cases reported to WHO and the first-line treatment regimen used in each country. Procurement data were obtained from procurement agencies, international organizations, WHO, national leishmaniasis programmes and manufacturers. Expert interviews were conducted to have a better understanding of how medicines were procured and used. The comparison of estimated need and procurement data indicated discrepancies in supply and demand at global level as well as in the most endemic countries. The extent of the gap in supply was up to 80% of the needs for one of the leishmaniasis medicines. Mismatch between supply and demand was much wider for cutaneous leishmaniasis than visceral leishmaniasis. This study presents a current picture of procurement patterns and imbalance in global supply and demand. Addressing improved access and supply barriers requires concerted and coordinated efforts at the global and national levels. Priority actions include setting up a procurement coordination mechanism among major procurers, partners and national programmes where forecasting and supply planning is jointly developed and communicated with manufacturers. In addition, continuous engagement of manufacturers and advocacy is critical to diversify the supplier base and ensure quality-assured and affordable generic medicines for leishmaniasis. |
| format | Article |
| id | doaj-art-cef4c0edaa8f4700955ea4bc6a334951 |
| institution | Kabale University |
| issn | 1935-2727 1935-2735 |
| language | English |
| publishDate | 2021-02-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Neglected Tropical Diseases |
| spelling | doaj-art-cef4c0edaa8f4700955ea4bc6a3349512025-08-20T03:25:19ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352021-02-01152e000918110.1371/journal.pntd.0009181The global procurement landscape of leishmaniasis medicines.Hye Lynn ChoiSaurabh JainJosé A Ruiz PostigoBettina BorischDaniel Argaw DagneEnsuring access to essential medicines for leishmaniasis control is challenging, as leishmaniasis is a very small and unattractive market for pharmaceutical industry. Furthermore, control programmes are severely underfunded. We conducted an analysis of global procurement of leishmaniasis medicines for the past 5 years in order to shed light on the current leishmaniasis market landscape and supply and demand dynamics. We estimated global demand of each leishmaniasis medicines, the amount of each medicine required to treat all reported cases, based on the number of cases reported to WHO and the first-line treatment regimen used in each country. Procurement data were obtained from procurement agencies, international organizations, WHO, national leishmaniasis programmes and manufacturers. Expert interviews were conducted to have a better understanding of how medicines were procured and used. The comparison of estimated need and procurement data indicated discrepancies in supply and demand at global level as well as in the most endemic countries. The extent of the gap in supply was up to 80% of the needs for one of the leishmaniasis medicines. Mismatch between supply and demand was much wider for cutaneous leishmaniasis than visceral leishmaniasis. This study presents a current picture of procurement patterns and imbalance in global supply and demand. Addressing improved access and supply barriers requires concerted and coordinated efforts at the global and national levels. Priority actions include setting up a procurement coordination mechanism among major procurers, partners and national programmes where forecasting and supply planning is jointly developed and communicated with manufacturers. In addition, continuous engagement of manufacturers and advocacy is critical to diversify the supplier base and ensure quality-assured and affordable generic medicines for leishmaniasis.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009181&type=printable |
| spellingShingle | Hye Lynn Choi Saurabh Jain José A Ruiz Postigo Bettina Borisch Daniel Argaw Dagne The global procurement landscape of leishmaniasis medicines. PLoS Neglected Tropical Diseases |
| title | The global procurement landscape of leishmaniasis medicines. |
| title_full | The global procurement landscape of leishmaniasis medicines. |
| title_fullStr | The global procurement landscape of leishmaniasis medicines. |
| title_full_unstemmed | The global procurement landscape of leishmaniasis medicines. |
| title_short | The global procurement landscape of leishmaniasis medicines. |
| title_sort | global procurement landscape of leishmaniasis medicines |
| url | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009181&type=printable |
| work_keys_str_mv | AT hyelynnchoi theglobalprocurementlandscapeofleishmaniasismedicines AT saurabhjain theglobalprocurementlandscapeofleishmaniasismedicines AT josearuizpostigo theglobalprocurementlandscapeofleishmaniasismedicines AT bettinaborisch theglobalprocurementlandscapeofleishmaniasismedicines AT danielargawdagne theglobalprocurementlandscapeofleishmaniasismedicines AT hyelynnchoi globalprocurementlandscapeofleishmaniasismedicines AT saurabhjain globalprocurementlandscapeofleishmaniasismedicines AT josearuizpostigo globalprocurementlandscapeofleishmaniasismedicines AT bettinaborisch globalprocurementlandscapeofleishmaniasismedicines AT danielargawdagne globalprocurementlandscapeofleishmaniasismedicines |